← Open Payments lookup

KELLY TRAN: Open Payments

NPI 1851773188 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$989 in 44 payments from 12 companies in 2025. Trend: 2023 $931 · 2024 $1,048 · 2025 $989

Food & beverage: $965Consulting: $24
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$232
GlaxoSmithKline, LLC.13$200
Takeda Pharmaceuticals U.S.A., Inc.7$159
Regeneron Healthcare Solutions, Inc.4$113
Novartis Pharmaceuticals Corporation4$96
Cycle Pharmaceuticals Inc2$48
GENZYME CORPORATION2$28
ARS Pharmaceuticals Operations, Inc.1$26
Pharming Healthcare, Inc.1$26
ADMA BioManufacturing LLC1$24

Products named: DUPIXENT, AIRSUPRA, TRELEGY ELLIPTA, NUCALA, CUVITRU, Rhapsido, TAKHZYRO, Sajazir.

Industry payments across NV — which companies pay providers there.